The board meeting for Cartesian Therapeutics Inc is scheduled for today, for the purpose of Cartesian Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Cartesian Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of -94.9%, and profit growth estimate of 21.0% for FY25, based on top 9 analyst calls.